SWITGLIM MV 1/0.2 (Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg))

SWITGLIM MV 1/0.2 is a medication typically used to help manage blood sugar levels in people with type 2 diabetes. It combines three active ingredients, each playing a role in supporting patients in maintaining a more stable glucose level after meals. By working together, these ingredients can help improve the body’s response to insulin and reduce the amount of sugar absorbed from food.

The active ingredients in SWITGLIM MV include Glimepiride, which stimulates the pancreas to produce more insulin; Metformin, which helps the body use insulin more effectively and decreases sugar production in the liver; and Voglibose, which slows down the digestion of carbohydrates in the intestine. Together, these components aim to provide a balanced approach to managing blood sugar levels.

For best results, it’s important to store SWITGLIM MV in a cool, dry place, away from direct sunlight. Consistent use, as directed by a healthcare provider, helps in achieving better control of blood sugar levels. Patients should also be mindful of any potential interactions with other medications and discuss any concerns with their doctor.

Some of the common, mild side effects may include stomach discomfort, nausea, or a mild headache. These effects are usually temporary and may resolve as the body adjusts to the medication.

This is general information, not a substitute for medical advice. Always consult a doctor/pharmacist and read the package leaflet.